Skip to main content
Top
Published in: Clinical Rheumatology 2/2008

01-12-2008 | Case Report

A case of Takayasu arteritis complicated by Castleman’s disease

Authors: Saeko Takahashi, Ikuo Kamiyama, Akitoshi Ishizaka

Published in: Clinical Rheumatology | Special Issue 2/2008

Login to get access

Abstract

We describe the first case of Takayasu Arteritis (TA) complicated by multicentric hyaline-vascular type of Castleman’s disease (CD) which was diagnosed by the biopsy of mediastinal lymphnode 23 years after the diagnosis of TA. CD is classified as a lymphoid disorder of immune regulation characterized by a systemic, unregulated B cell proliferation, and there are some reports about the coincidence of CD and autoimmune diseases. This case has allowed us to gain some insight into a possible relation between the two disorders.
Literature
1.
go back to reference Ben-Chetrit E, Flusser D, Okon E et al (1989) Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen. Ann Rheum Dis 48:326–330PubMedCrossRef Ben-Chetrit E, Flusser D, Okon E et al (1989) Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen. Ann Rheum Dis 48:326–330PubMedCrossRef
2.
go back to reference Jacobs SA, Vidnovic N Patel H et al (2007) Durable remission of HIV-negative, Kaposi's sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate. Clin Rheumatol 26:1148–1150PubMedCrossRef Jacobs SA, Vidnovic N Patel H et al (2007) Durable remission of HIV-negative, Kaposi's sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate. Clin Rheumatol 26:1148–1150PubMedCrossRef
3.
go back to reference Suwannaroj S, Elkins SL, McMurray RW (1999) Systemic lupus erythematosus and Castleman's disease. J Rheumatol 26:1400–1403PubMed Suwannaroj S, Elkins SL, McMurray RW (1999) Systemic lupus erythematosus and Castleman's disease. J Rheumatol 26:1400–1403PubMed
4.
go back to reference Chorzelski T, Hashimoto T, Maciejewska B et al (1999) Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol 41:393–400PubMedCrossRef Chorzelski T, Hashimoto T, Maciejewska B et al (1999) Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol 41:393–400PubMedCrossRef
5.
go back to reference Pacor ML, Peroli P, Givanni S et al (1990) Unicentric Castleman's lymphadenopathy presenting with Behçet's syndrome: a case report. Haematologica 75:470–472PubMed Pacor ML, Peroli P, Givanni S et al (1990) Unicentric Castleman's lymphadenopathy presenting with Behçet's syndrome: a case report. Haematologica 75:470–472PubMed
6.
go back to reference Lajoie G, Kumar S, Min KW et al (1995) Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases. Am J Surg Pathol 19:1021–1028PubMedCrossRef Lajoie G, Kumar S, Min KW et al (1995) Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases. Am J Surg Pathol 19:1021–1028PubMedCrossRef
7.
go back to reference Couch WD (1980) Giant lymph node hyperplasia associated with thrombotic thrombocytopenic purpura. Am J Clin Pathol 74:340–344PubMed Couch WD (1980) Giant lymph node hyperplasia associated with thrombotic thrombocytopenic purpura. Am J Clin Pathol 74:340–344PubMed
8.
go back to reference Nanki T, Tomiyama J, Arai S (1994) Mixed connective tissue disease associated with multicentric Castleman's disease. Scand J Rheumatol 23:215–217PubMedCrossRef Nanki T, Tomiyama J, Arai S (1994) Mixed connective tissue disease associated with multicentric Castleman's disease. Scand J Rheumatol 23:215–217PubMedCrossRef
9.
go back to reference Noris M, Daina E, Gamba S et al (1999) Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation 100(1):55–60PubMed Noris M, Daina E, Gamba S et al (1999) Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation 100(1):55–60PubMed
10.
go back to reference Brandt SJ, Bodine DM, Dunbar CE et al (1990) Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 86:592–599PubMedCrossRef Brandt SJ, Bodine DM, Dunbar CE et al (1990) Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 86:592–599PubMedCrossRef
Metadata
Title
A case of Takayasu arteritis complicated by Castleman’s disease
Authors
Saeko Takahashi
Ikuo Kamiyama
Akitoshi Ishizaka
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue Special Issue 2/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-1014-x

Other articles of this Special Issue 2/2008

Clinical Rheumatology 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.